Cargando…

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and has strong immunogenicity. A systematically investigation of the tumor microenvironment (TME) in ccRCC could contribute to help clinicians develop personalized treatment and facilitate clinical decision-making. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Weimin, Li, Yinan, Yuan, Yichu, Zhong, Hongbin, Huang, Chaoqun, Huang, Jiwei, Lin, Yao, Huang, Jiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495029/ https://www.ncbi.nlm.nih.gov/pubmed/34631713 http://dx.doi.org/10.3389/fcell.2021.736540

Ejemplares similares

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
por: Zhong, Weimin, et al.
Publicado: (2021)

Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma
por: Zhong, Weimin, et al.
Publicado: (2022)

Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology
por: Zhong, Weimin, et al.
Publicado: (2023)

Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC)
por: Zhong, Weimin, et al.
Publicado: (2021)

Ubiquitin Modification Patterns of Clear Cell Renal Cell Carcinoma and the Ubiquitin Score to Aid Immunotherapy and Targeted Therapy
por: Zhou, Peng, et al.
Publicado: (2021)

Identification of 12 immune-related lncRNAs and molecular subtypes for the clear cell renal cell carcinoma based on RNA sequencing data
por: Zhong, Weimin, et al.
Publicado: (2020)

Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric Cancer
por: Li, Fang, et al.
Publicado: (2022)

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
por: Gao, Ze, et al.
Publicado: (2021)

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
por: Tang, Gang, et al.
Publicado: (2022)

Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
por: Hu, Rixin, et al.
Publicado: (2022)

Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps
por: Quan, Jing, et al.
Publicado: (2022)

T Cell Membrane Heterogeneity Aids Antigen Recognition and T Cell Activation
por: Farrell, Megan V., et al.
Publicado: (2020)

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma
por: Zhou, Haiting, et al.
Publicado: (2023)

A novel lipid metabolism gene signature for clear cell renal cell carcinoma using integrated bioinformatics analysis
por: Li, Ke, et al.
Publicado: (2023)

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021)

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
por: Li, Xiushen, et al.
Publicado: (2021)

Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy
por: Li, Zhengshuo, et al.
Publicado: (2021)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

LncRNA DGCR5 Isoform-1 Silencing Suppresses the Malignant Phenotype of Clear Cell Renal Cell Carcinoma via miR-211-5p/Snail Signal Axis
por: Zhong, Guang-Xin, et al.
Publicado: (2021)

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
por: Melo, Vinicio, et al.
Publicado: (2022)

Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma
por: Lv, Daojun, et al.
Publicado: (2021)

Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022)

External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021)

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
por: Canning, Madison, et al.
Publicado: (2019)

CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling
por: Wang, Xinjun, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation
por: Lu, Wenqing, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Wang, Song, et al.
Publicado: (2021)

The combination of NDUFS1 with CD4(+) T cell infiltration predicts favorable prognosis in kidney renal clear cell carcinoma
por: Wu, Dong, et al.
Publicado: (2023)

Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma
por: Zhang, Yiyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rv7f721dudnme7q4p5ev3j1elj